ScoreWhy is CellaVision AB ?
1
Poor long term growth as Operating profit has grown by an annual rate 12.88% of over the last 5 years
2
Flat results in Jun 26
- OPERATING CASH FLOW(Y) Lowest at SEK 172.6 MM
- NET PROFIT(HY) At SEK 55.14 MM has Grown at -30.32%
- ROCE(HY) Lowest at 15.11%
3
With ROE of 14.66%, it has a fair valuation with a 3.20 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.74%, its profits have fallen by -11.9%
4
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 27.70% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -8.74% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CellaVision AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CellaVision AB
-8.74%
9.30
44.90%
OMX Stockholm 30
27.7%
1.79
15.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.99%
EBIT Growth (5y)
12.88%
EBIT to Interest (avg)
25.77
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.86
Tax Ratio
20.97%
Dividend Payout Ratio
42.85%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
25.37%
ROE (avg)
19.18%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
3.20
EV to EBIT
15.69
EV to EBITDA
12.79
EV to Capital Employed
3.85
EV to Sales
3.72
PEG Ratio
NA
Dividend Yield
0.01%
ROCE (Latest)
24.55%
ROE (Latest)
14.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -4.06% (YoY
CASH AND EQV(HY)
Highest at SEK 402.41 MM
NET SALES(Q)
Highest at SEK 199.89 MM
-7What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at SEK 172.6 MM
NET PROFIT(HY)
At SEK 55.14 MM has Grown at -30.32%
ROCE(HY)
Lowest at 15.11%
Here's what is working for CellaVision AB
Net Sales
Highest at SEK 199.89 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Cash and Eqv
Highest at SEK 402.41 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -4.06% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at SEK 13.37 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SEK MM)
Here's what is not working for CellaVision AB
Operating Cash Flow
Lowest at SEK 172.6 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Net Profit
At SEK 55.14 MM has Grown at -30.32%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
